Aroplatin (Liposomal NDDP, L-NDDP)

DRUG3 trials

Sponsors

Aronex Pharmaceuticals

Conditions

Colorectal NeoplasmsEsophageal NeoplasmsHepatocellular CarcinomaNeoplasmsOvarian NeoplasmsPancreatic Neoplasms

Phase 1

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Aronex PharmaceuticalsColorectal Neoplasms, Esophageal Neoplasms, Hepatocellular Carcinoma +3

Target: 40Updated: 2005-06-24

Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies

Aronex PharmaceuticalsPancreatic Neoplasms

Target: 111Updated: 2005-06-24

Phase 2

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Aronex PharmaceuticalsColorectal Neoplasms

Target: 40Updated: 2005-06-24